- Home
- CCCC vs BCV Comparison
CCCC vs BCV Comparison
Compare CCCC & BCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCCC
- BCV
- Stock Information
- Founded
- CCCC 2015
- BCV 1971
- Country
- CCCC United States
- BCV United States
- Employees
- CCCC N/A
- BCV N/A
- Industry
- CCCC Biotechnology: Pharmaceutical Preparations
- BCV Finance/Investors Services
- Sector
- CCCC Health Care
- BCV Finance
- Exchange
- CCCC Nasdaq
- BCV Nasdaq
- Market Cap
- CCCC 104.4M
- BCV 104.8M
- IPO Year
- CCCC 2020
- BCV N/A
- Fundamental
- Price
- CCCC $1.54
- BCV $18.67
- Analyst Decision
- CCCC Buy
- BCV
- Analyst Count
- CCCC 3
- BCV 0
- Target Price
- CCCC $12.00
- BCV N/A
- AVG Volume (30 Days)
- CCCC 1.0M
- BCV 26.3K
- Earning Date
- CCCC 07-31-2025
- BCV 01-01-0001
- Dividend Yield
- CCCC N/A
- BCV 8.13%
- EPS Growth
- CCCC N/A
- BCV N/A
- EPS
- CCCC N/A
- BCV N/A
- Revenue
- CCCC $39,783,000.00
- BCV N/A
- Revenue This Year
- CCCC N/A
- BCV N/A
- Revenue Next Year
- CCCC N/A
- BCV N/A
- P/E Ratio
- CCCC N/A
- BCV N/A
- Revenue Growth
- CCCC 98.56
- BCV N/A
- 52 Week Low
- CCCC $1.09
- BCV $14.09
- 52 Week High
- CCCC $7.66
- BCV $18.11
- Technical
- Relative Strength Index (RSI)
- CCCC 50.55
- BCV 63.88
- Support Level
- CCCC $1.36
- BCV $18.17
- Resistance Level
- CCCC $1.63
- BCV $18.49
- Average True Range (ATR)
- CCCC 0.14
- BCV 0.19
- MACD
- CCCC -0.00
- BCV -0.01
- Stochastic Oscillator
- CCCC 38.33
- BCV 89.71
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
About BCV Bancroft Fund Ltd.
Bancroft Fund Ltd is a diversified closed-end management company. It operates as a closed-ended equity mutual fund. The funds' main objective is to provide income and potential for capital appreciation. With the intent to achieve its objective, the company invests in convertible and equity securities. It invests across different industries such as Computer Software and Services, Energy and Utilities, Health Care among others.